Neuroleptic malignant syndrome in the intensive therapy unit.
A case of the neuroleptic malignant syndrome occurred in a 40-year-old male after administration of chlorpromazine while on an Intensive Therapy Unit. Treatment with dantrolene sodium was successful, and a muscle biopsy was examined in the recovery phase of the illness. The importance of this condition and the difficulties in establishing a diagnosis at an early stage in patients on an Intensive Therapy Unit are discussed, along with implications for treatment.
Montgomery
J N
JN
Department of Anaesthesia and Intensive Therapy, Whipps Cross Hospital, London.
Ironside
J W
JW
D000328:Adult; D001706:Biopsy; D002746:Chlorpromazine / Q000009:adverse effects*; D003422:Critical Care; D006801:Humans; D008297:Male; D009132:Muscles / Q000473:pathology*; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology
D002746:Chlorpromazine